Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/187066
Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background: Estimates of the humoral immune response to incident human papillomavirus (HPV) infections are limited. Methods: In this post hoc analysis of 3875 women aged 16-23 years from a 4-valent HPV vaccine trial (NCT00092482), HPV seroprevalence on day 1 was measured with a 9-valent HPV (HPV 6/11/16/18/31/33/45/ 52/58) competitive Luminex immunoassay and compared with cervical/external genital HPV detection by po-lymerase chain reaction. In the control group, among women who were HPV DNA-negative on day 1, sero-conversion following initial HPV detection was estimated using Kaplan-Meier methods. Results: Type-specific HPV seropositivity among women with no day 1 cervical/external genital HPV detection was 0.6%-3.6%. Women with any 9-valent HPV (9vHPV) cervical/external genital detection (796/3875; 20.5%) had concordant seropositivity ranging from 13.4% (HPV 45) to 38.5% (HPV 6). Among women in the control group who were negative for all HPV types on day 1, seroconversion by month 30 after initial detection ranged from 29% (HPV 45) to 75% (HPV 16). Conclusions: Humoral immune response to HPV is variable and dynamic, depending on type-specific exposure. This longitudinal analysis provides insight into the relationship between incident infection and seropositivity.
Matèries
Matèries (anglès)
Citació
Citació
BROWN, Darron r., CASTELLSAGUÉ, Xavier, FERRIS, Daron, GARLAND, Suzanne m., HUH, Warner, STEBEN, Marc, WHEELER, Cosette m., SAAH, Alfred, LUXEMBOURG, Alain, LI, Se, VELICER, Christine. Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women. _Tumour Virus Research_. 2022. Vol. 13. [consulta: 21 de gener de 2026]. ISSN: 2666-6790. [Disponible a: https://hdl.handle.net/2445/187066]